Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raytheon BBN Technologies is a premier research and development center that applies advanced computing and engineering to solve complex problems, including those in the life sciences and healthcare sectors. The company's life sciences division focuses on synthetic biology, bioinformatics, and the development of predictive models for biological systems, often through high-profile government contracts. BBN is a key player in DARPA-funded initiatives, developing platforms for automated biological design, biosecurity, and the detection of engineered organisms. Their expertise extends to medical informatics and speech recognition technologies tailored for healthcare environments. As a subsidiary of RTX Corporation, BBN bridges the gap between fundamental academic research and practical technological applications for defense and health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BBN Technologies.